Worsening of inflammation during infectious processes.
Until now, no severe allergic reactions have been reported with ibuprofen 600 mg, although they cannot be ruled out. Manifestations of this type of reaction could be fever, skin rash, abdominal pain, severe headache, nausea, vomiting, facial swelling, tongue, and throat swelling, difficulty breathing, asthma, palpitations, hypotension, or shock.
If any of the following side effects occur, stop treatment and seek medical attention immediately:
Reporting of adverse reactions
If you experience any type of adverse reaction, consult your doctor, pharmacist, or nurse, even if it is a possible adverse reaction that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse reactions, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 30°C.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Ibuprofeno Stada
Core
Croscarmelosa sodium, hypromellose, lactose monohydrate, microcrystalline cellulose, pregelatinized cornstarch, anhydrous colloidal silica, magnesium stearate, purified water.
Coating
Hypromellose, titanium dioxide (E-171), talc, purified water, and propylene glycol.
Appearance of the product and content of the container
Ibuprofeno Stada is presented in the form of coated tablets with a film coating, oval, biconvex, and white in color.
Ibuprofeno Stada is available in blister packs containing 20, 40, or 500 (clinical pack) tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Laboratorio STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Responsible for manufacturing:
FARMALIDER, S.A,
Aragoneses, 2
28108 Alcobendas
Madrid Spain
o
FROSST IBÉRICA, S.A.,
Vía Complutense, 140,
28805 Alcalá de Henares Spain
Madrid
o
TOLL MANUFACTURING SERVICES S.L.
C/Aragoneses,2
28108 Alcobendas (Madrid) Spain
Date of the last review of this prospectus: October 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.